Moderator Scott Gottlieb, MD, asked panel members about the current trend toward value-based models in terms of healthcare reimbursement, and how they would define value-based care and what they believe is the ultimate goal in changing to this model.
Kavita Patel, MD, MS, indicated that “value-based care” is still not well-defined. What the administration is trying to do is change the infrastructure of the payment model. Rather than continuing with a volume-based payment model, the current administration wants to manage health with an interdisciplinary approach under a global payment structure. And while national legislation has helped with this shift in models, as with the Medicare Access and Chip Reauthorization Act, the transition will be difficult.
John L. Fox, MD, MHA, agreed that changing over payment models would be a challenge, especially within a 3-year time span. Hospital and system administrators have seen that the only way to get more healthcare dollars is by going “at-risk.” Profit margins are as high as ever, Dr Fox said, and there’s less momentum to become an accountable care organization (ACO).
“The other irony of this is… that right now the arrangements are for gainsharing only and the behavioral economist will tell you that you work a lot harder when you have something to lose than when you have something to gain,” Dr Fox stated. The big question, then, is will people be willing to change their models and take risks once it’s mandated, especially when the imperative to take those risks has been taken away?
Ted Okon agreed with Drs Fox and Patel, adding that gainsharing is like competing against oneself and, thus, not a viable option. Larger health systems, for example, are already pulling out.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More